Results 191 to 200 of about 57,324 (279)

Contemporary Analysis of VTE Risk After HPB Surgery: 2517 Consecutive Patients Treated With Extended Chemoprophylaxis

World Journal of Surgery, Volume 50, Issue 6, Page 1663-1665, June 2026.
Independent predictors of Venous Thromboembolism (VTE) within the first 45 post‐operative days on multivariate analyses.
Anish J. Jain, Esther N. Dekker, Laura Prakash, Elsa M. Arvide, Yi‐Ju Chiang, Rebecca A. Snyder, Matthew H. G. Katz, Ching‐Wei D. Tzeng   +7 more
wiley   +1 more source

Alkaloids from Evodia rutaecarpa inhibit the occurrence and development of gallbladder cancer in vivo and in vitro. [PDF]

Sci Rep
Li Y, Zhou S, Xu H, Zhou H, Sun K, Hu S, Xu K, Yang J, Chen Y, Li W.   +9 more
europepmc   +1 more source

Predictive Immunohistochemistry in Cholangiocarcinoma: Current Clinical Utility, Practical Limitations, and Emerging Directions

APMIS, Volume 134, Issue 6, June 2026.
ABSTRACT Cholangiocarcinoma (CCA) remains a difficult‐to‐treat biliary malignancy in which therapeutic stratification increasingly depends on predictive biomarkers. Although next‐generation sequencing is essential for the detection of targetable genomic alterations, immunohistochemistry (IHC) retains a practical role because it is widely available ...
Francesco Vasuri, Alessandra Boccaccino, Stefano Tamberi, Luca Saragoni   +3 more
wiley   +1 more source

The B7 family subgroup reflects tumor cell heterogeneity and patient post-operative prognosis in gallbladder cancer. [PDF]

Biol Direct
Ma C, Hu H, Li Y, Zhong C, Dong Y, Chang Z, Xu S, Zhang Y, Hu H, Lv C, Tian Y.   +10 more
europepmc   +1 more source

Aquaporin‐1 differentiates intrahepatic cholangiocarcinoma from liver metastases of pancreatic ductal adenocarcinoma

Histopathology, Volume 88, Issue 7, Page 1360-1372, June 2026.
Differentiating intrahepatic CCA from PDAC metastatic to the liver is critical for the clinical management of patients with pancreatobiliary cancers. AQP1 has demonstrated an excellent discriminatory performance in this clinical scenario. Aims Differentiating intrahepatic cholangiocarcinoma (iCCA) from metastatic ductal adenocarcinoma of the pancreas ...
Leoncini Giuseppe, Barella Marco, Droz Dit Busset Michele, Gentili Marco, Bodini Beatrice, Ronchetti Simona, Cari Luigi, Mazzaferro Vincenzo   +7 more
wiley   +1 more source

GPX3 suppresses gallbladder cancer progression by modulating redox balance, glycolysis, and anti-tumor immunity. [PDF]

Oncogenesis
Ma Z, Sun J, Wu X, Shang C, Li B.
europepmc   +1 more source

Changes in the 6th edition of the World Health Organization classification of tumours of the digestive system

Histopathology, Volume 88, Issue 7, Page 1295-1314, June 2026.
Changes and new entities in the 6th edition WCT of the digestive system, including structural, molecular, and diagnostic updates to standardize terminology and improve clinical relevance. Epithelial tumours are organized by site; neuroendocrine, mesenchymal and haematolymphoid tumours have dedicated chapters, with refined grading, redefined ...
Mark J Arends, Irene Esposito, Anthony J Gill, Ralph H Hruban, Joseph D Khoury, Motohiro Kojima, Elizabeth A Montgomery, Fatimah Abdulkareem, Fátima Carneiro, Guido Costamagna, Gregory Lauwers, Alexandros D Polydorides, Guido Rindi, Massimo Rugge, Peter Schirmacher, Amitabh Srivastava, James Yao, Jennelle C Hodge, James G Kench, Bharat Rekhi, Miguel Reyes‐Múgica, Antonia R Sepulveda, Chanjuan Shi, Pavitratha Puspanathan, Harshima Wijesinghe, Christine Giesen, Blanca Iciar Indave Ruiz, Dilani Lokuhetty, WCT standing editorial board, Iris D Nagtegaal, Wendy Cooper, Michael Eden, Andrew Field, Vicky Goh, Jennelle Hodge, James Kench, Joseph Khoury, Katia Leite, Zhiyong Liang, Daichi Maeda, George Netto, Bharat Rekhi, Miguel Reyes Múgica, Brian Rous, Ales Ryska, Shahin Sayed, Antonia R Sepulveda, Chanjuan Shi, Gary Tse   +48 more
wiley   +1 more source

Survival benefit of adjuvant radiotherapy for gallbladder cancer patients with stage IIIA: a population based, propensity score-matched study. [PDF]

Transl Cancer Res
Zhao X, Qiao Y, He L, Ran C.
europepmc   +1 more source

Annual magnetic resonance cholangiopancreatography surveillance outcomes in individuals with primary sclerosing cholangitis

Internal Medicine Journal, Volume 56, Issue 6, Page 1026-1032, June 2026.
Abstract Background Annual surveillance for cholangiocarcinoma using magnetic resonance cholangiopancreatography (MRCP) has been recommended in primary sclerosing cholangitis (PSC) to improve the associated dismal outcomes. However, data are limited. Aims To compare the outcomes of surveillance versus non‐surveillance in patients with PSC.
Gary Dezhi Zhang, Chloe Attree, Nazneen Irani, Jonathan Tibballs, John Ferguson, Luis Calzadilla Bertot, Michael Wallace, Briohny Smith, George Garas, Gary Jeffrey, Leon Anton Adams, Gerry MacQuillan   +11 more
wiley   +1 more source